28 research outputs found
Improved Outcomes of Breast-Conserving Therapy for Patients With Ductal Carcinoma in Situ
The Role of the Number of Uninvolved Lymph Nodes in Predicting Locoregional Recurrence in Breast Cancer
Anastrozole versus tamoxifen in postmenopausal women with ductal carcinoma in situ undergoing lumpectomy plus radiotherapy (NSABP B-35):Â a randomised, double-blind, phase 3 clinical trial
The Consensus Conference on the Treatment of In Situ Ductal Carcinoma of the Breast, 22–25 April 1999
Significance of Multifocality in Ductal Carcinoma In Situ: Outcomes of Women Treated With Breast-Conserving Therapy
Breast cancer and molecular medicine
As molecular-based medicine takes center stage due to the increasing knowledge of breast cancer molecular biology treatment tailoring is no longer a dream for the future but the main goal of current research. This book provides an overview of the most recent techniques, agents and approaches for breast cancer contributing to the individualization of treatment. Current biomedical research focuses on facilitating the transfer of molecular biology knowledge into the clinical management of patients, leading to increased survival as well as improved quality of life. Particular attention is given here to organ-specific tailored approaches, specific populations, patients' preferences and rehabilitation. Also discussed in depth are the respective roles of pharmacotherapeutics modelling, functional imaging, molecular staging, genomics and proteomics and their impact on the "re-classification" of breast cancer, as well as the clinical applications of basic science. The crucial issues of how to best integrate biological markers, new technologies, and new diagnostic and therapeutic approaches into clinical trials and practice are addressed. © Springer-Verlag Berlin Heidelberg 2006. All rights reserved.SCOPUS: bk.binfo:eu-repo/semantics/publishe